SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000940394-07-000100
Filing Date
2007-01-29
Accepted
2007-01-29 17:01:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 12/31/06 NPS PHARMACEUTICALS 13G npspharm13g.txt SC 13G 5039
  Complete submission text file 0000940394-07-000100.txt   6657
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44877 | Film No.: 07561738
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 24 FEDERAL STREET BOSTON MA 02110
EATON VANCE MANAGEMENT (Filed by) CIK: 0001076598 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G